91+ 8919121300

admin@renovatebio.com

Procise dx

ProciseDx gives lab-quality quantitative results—

We enable gastroenterologists to make treatment decisions in less than 5 minutes and without compromising lab-quality results.

Great improvements in therapy of Inflammatory Bowel diseases have been made for patients and especially with the rise of TNFα.

  • Studies and key opinion leaders agree that physicians should consistently monitor these therapeutic treatments to achieve the best results.
  • Our drug monitoring assays will provide you results from fingerprick whole blood in less than 5 minutes enabling decisions at time of treatment.
  • Lab-quality answers. In-office easy.

    Welcome to immediate clinical decisions during visits.

    Meet ProciseDx, your new partner for point-of-care solutions. Our platform is optimized for quantitative immunoassays, making it simple to get lab quality results - in real time, right in your office. Leveraging proven technology and patented chemistry, we’re delivering diagnostic answers that allow immediate actions. It’s a new normal that makes patient visits more productive than ever, and turn any site into a powerhouse for patient care.

    Using trFRET and proprietary Lumiphore™ technology, we can achieve speed and quantitation never before seen in immunoassays.
    Excitation

    A flash of uv light is used to excite the sample

    Background

    Many biological materials fluoresce with uv excitation,but fade quickly Overtime.

    Tr-FRET

    lUMIPHORE Technology allows for a long-lived fluorescent emission much longer than biological materials

    Our platform is fully operational and in our first clinical trial.

    CE marks have been attained for the instrument and our first assay: CRP.

    Our tests incorporate established chemistry with proprietary compounds to enable rapid and quantitative results. The system is compatible with a variety of specimen types, including; finger prick whole blood, venous blood, serum, plasma, urine, saliva and stool samples.

    “With ProciseDx, we will be able to measure levels of infliximab and adalimumab in five minutes from fingerstick blood. This information during the patient visit will be incorporated into our immediate treatment decisions.”